Pediatric hidradenitis suppurativa faces diagnostic delays and stigma, while adalimumab shows superior drug survival compared ...

Managing IBD in patients with CKD requires an individualized, stage-adjusted dosing strategy with vigilant renal monitoring, particularly in those with more advanced stages of renal disease.

US FDA accepts resubmitted NDA of Aldeyra Therapeutics for review of topical ocular reproxalap to treat dry eye disease: Lexington, Massachusetts Saturday, July 19, 2025, 13:00 Hr ...

Cat’s-claw, chaparral, and blue-green algae (spirulina) supplements for rheumatoid arthritis may do more harm than good.

The global chronic plaque psoriasis market is experiencing steady growth, propelled by increasing autoimmune disease prevalence and advancements in biologic therapies. Affecting 2-3% of the global ...

Our Bureau, Mumbai Monday, July 21, 2025, 16:30 Hrs [IST] ...

Treatments for uveitic macular edema, including systemic and local options, were among the topics debated at the Congress on Controversies in Ophthalmology.

Drug shortages have surged, highlighting the need for a resilient pharmaceutical supply chain. Onshoring and AI are key to ...

The use of dual biologic disease-modifying antirheumatic drug (bDMARD) with JAK inhibitor (JAKi ... to receive a one-time intramuscular injection of corticosteroid and oral methotrexate for 1 year, or ...

Tildrakizumab is an interleukin-23 antagonist approved under the brand name Ilumya for the treatment of plaque psoriasis.

A 40-year-old woman presents with a very itchy bilateral rash on her ankles and feet, present for a few months. She has a few ...

Certain medications and supplements can make your skin more sensitive to the sun, making you more prone to sunburn and other ...